Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin

Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin

  • CN 102,395,888 A
  • Filed: 04/14/2010
  • Published: 03/28/2012
  • Est. Priority Date: 04/14/2009
  • Status: Active Application
First Claim
Patent Images

1. diagnostic method, it is used to identify the experimenter who suffers from by give the primary noninfectious disease that bad risk as a result that microbiotic possibly induce increases to the experimenter, said method comprises following steps:

  • (i) the said experimenter'"'"'s who suffers from the primary noninfectious disease humoral sample is provided,(ii) measure Procalcitonin in the said sample (PCT) or its fragment or precursor, or the fragment with at least 12 amino acid residue length of said precursor,(iii) with measured level be associated by giving the possible risk that microbiotic induces.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×